Zimbabwe rejects 'lopsided' US health aid deal over data concerns

Zimbabwe has declined a health aid agreement with the United States, citing concerns over access to biological samples and the lack of benefit-sharing from US research. The government expressed that the deal was 'lopsided' and did not adequately address the needs and rights of Zimbabwean citizens regarding their biological data. This decision highlights the ongoing tensions between Zimbabwe and the US regarding health aid and research collaboration. The rejection of the deal indicates a broader concern about sovereignty and equitable partnerships in international health initiatives. Zimbabwe's stance reflects a desire for more balanced agreements that respect local interests and contributions.

• Zimbabwe rejected a US health aid deal.
• Concerns over access to biological samples were raised.
• The US did not want to share research benefits.
• The deal was described as 'lopsided' by Zimbabwean officials.
• This rejection highlights issues of sovereignty in health partnerships.